Skip to main content

Advertisement

Table 1 Prevalence of IL28B genotypes in Hungarian HCV patients and healthy controls

From: IL28B and IL10R −1087 polymorphisms are protective for chronic genotype 1 HCV infection and predictors of response to interferon-based therapy in an East-Central European cohort

IL28B genotype HCV1 (n = 748) Controls (n = 105) OR
CC 195 (26.1%) 54 (51.4%) 0.333 (0.22 - 0.505)
P < 0.001
CT 411 (54.9%) 39 (37.1%) 2.064 (1.354 - 3.145)
p = 0.001
C allele 606 (81.02%) 93 (88.6%) 0.551 (0.294-1.032)
p = 0.059
TT 142 (19.0%) 12 (11.4%) 1.816 (0.969 – 3.404)
p = 0.059
T allele (non-CC) 553 (73.9%) 51 (48.6%) 3.003 (1.981 – 4.552)
    P < 0.001